Transdermal entry of yeast components elicits transient B cell-associated responses in skin-draining lymph nodes

Cell Immunol. 2020 Sep:355:104159. doi: 10.1016/j.cellimm.2020.104159. Epub 2020 Jul 10.

Abstract

Immune responses to non-pathogenic yeasts induced within the draining lymph node remain to be understood. In this study, we have investigated the changes in lymphocytes and their activity in skin-draining lymph nodes in response to transdermally injected zymosan (component of the yeast cell wall). Zymosan elicited the transient increase of B cell number and activation status without affecting the capacity for proliferation. The increased B cell content in the regional lymph nodes was likely due to the reduction of B cell egress from the tissue and in part the increase of homing from the circulation. Zymosan also upregulated the inflammatory cytokines, such as IL-1β, IL-6, IL-12, and IFNγ, regulatory cytokines IL-10 and TGFβ, and lymphoid chemokine CXCL13. Among these, the expression of IL-12 and IL-10 was markedly high in B cells. Altogether, these findings demonstrate a unique B cell-associated response to non-pathogenic yeast component in the draining lymph nodes. This will provide insights into the clinical and healthcare applications of non-pathogenic beneficial microbes.

Keywords: B cells; Skin-draining lymph node; Yeast; Zymosan.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Animals
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology*
  • Cytokines / metabolism
  • Female
  • Interleukin-10 / metabolism
  • Interleukin-12 / metabolism
  • Lymph Nodes / drug effects
  • Lymph Nodes / immunology*
  • Lymph Nodes / physiology
  • Lymphocytes / immunology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Skin / drug effects
  • Skin / immunology*
  • Zymosan / pharmacology

Substances

  • Cytokines
  • Interleukin-10
  • Interleukin-12
  • Zymosan